IDEAS home Printed from https://ideas.repec.org/a/wly/hlthec/v7y1998i1p21-29.html
   My bibliography  Save this article

Faecal occult blood screening for colorectal cancer: is it cost‐effective?

Author

Listed:
  • David K. Whynes
  • Aileen R. Neilson
  • Andrew R. Walker
  • Jack D. Hardcastle

Abstract

Recently published evidence from two large‐scale clinical trials conducted in England and in Denmark suggests that faecal occult blood screening for colorectal cancer significantly reduces mortality. However, before screening can be advocated as part of national health policy, its cost‐effectiveness must be demonstrated. The English screening trial has been the subject of a detailed economic evaluation over the past 10 years. In this paper, cost‐effectiveness estimates of screening are presented, based on cost and outcome data combined in a mathematical model developed from the trial's clinical findings. The estimates of cost per quality‐adjusted life‐year gained from colorectal cancer screening show the procedure to be of similar cost‐effectiveness to breast cancer screening in the short term. Over the longer term, however, the estimates for colorectal cancer screening appear superior. © 1998 John Wiley & Sons, Ltd.

Suggested Citation

  • David K. Whynes & Aileen R. Neilson & Andrew R. Walker & Jack D. Hardcastle, 1998. "Faecal occult blood screening for colorectal cancer: is it cost‐effective?," Health Economics, John Wiley & Sons, Ltd., vol. 7(1), pages 21-29, February.
    • Handle: RePEc:wly:hlthec:v:7:y:1998:i:1:p:21-29
    DOI: 10.1002/(SICI)1099-1050(199802)7:1<21::AID-HEC306>3.0.CO;2-9
    as

    Download full text from publisher

    File URL: https://doi.org/10.1002/(SICI)1099-1050(199802)7:13.0.CO;2-9
    Download Restriction: no
    File URL: https://libkey.io/10.1002/(SICI)1099-1050(199802)7:1<21::AID-HEC306>3.0.CO;2-9?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. David K. Whynes & Aileen R. Neilson, 1993. "Convergent validity of two measures of the quality of life," Health Economics, John Wiley & Sons, Ltd., vol. 2(3), pages 229-235, October.
    2. Andrew Walker & David K. Whynes, 1992. "Filtering Strategies in Mass Population Screening for Colorectal Cancer," Medical Decision Making, , vol. 12(1), pages 2-7, February.
    3. John Cairns, 1992. "Discounting and health benefits: Another Perspective," Health Economics, John Wiley & Sons, Ltd., vol. 1(1), pages 76-79, April.
    4. Neilson, Aileen R. & Whynes, David K., 1995. "Determinants of persistent compliance with screening for colorectal cancer," Social Science & Medicine, Elsevier, vol. 41(3), pages 365-374, August.
    5. Michael Parsonage & Henry Neuburger, 1992. "Discounting and health benefits," Health Economics, John Wiley & Sons, Ltd., vol. 1(1), pages 71-76, April.
    6. Karen Gerard & Gavin Mooney, 1993. "Qaly league tables: Handle with care," Health Economics, John Wiley & Sons, Ltd., vol. 2(1), pages 59-64, April.
    7. David K. Whynes & Andrew R. Walker & Jack D. Hardcastle, 1992. "Cost savings in mass population screening for colorectal cancer resulting from the early detection and excision of adenomas," Health Economics, John Wiley & Sons, Ltd., vol. 1(1), pages 53-60, April.
    8. Walker, Andrew & Whynes, David K., 1991. "Participation and screening programmes for colorectal cancer: More would be better?," Journal of Health Economics, Elsevier, vol. 10(2), pages 207-225, July.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Whynes, David K. & Frew, Emma & Wolstenholme, Jane L., 2003. "A comparison of two methods for eliciting contingent valuations of colorectal cancer screening," Journal of Health Economics, Elsevier, vol. 22(4), pages 555-574, July.
    2. Magnus Johannesson & David Meltzer, 1998. "Editorial: Some reflections on cost‐effectiveness analysis," Health Economics, John Wiley & Sons, Ltd., vol. 7(1), pages 1-7, February.
    3. Panos Kanavos & Willemien Schurer, 2010. "The dynamics of colorectal cancer management in 17 countries," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 10(1), pages 115-129, January.
    4. Emma J. Frew & David K. Whynes & Jane L. Wolstenholme, 2003. "Eliciting Willingness to Pay: Comparing Closed-Ended with Open-Ended and Payment Scale Formats," Medical Decision Making, , vol. 23(2), pages 150-159, March.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. John Hutton, 2012. "‘Health Economics’ and the evolution of economic evaluation of health technologies," Health Economics, John Wiley & Sons, Ltd., vol. 21(1), pages 13-18, January.
    2. Nancy Thiry & Philippe Beutels & Pierre Damme & Eddy Doorslaer, 2003. "Economic Evaluations of Varicella Vaccination Programmes," PharmacoEconomics, Springer, vol. 21(1), pages 13-38, January.
    3. Andrew Briggs, 1995. "Handling Uncertainty in the Results of Economic Evaluation," Briefing 000410, Office of Health Economics.
    4. Erik Nord, 2011. "Discounting future health benefits: the poverty of consistency arguments," Health Economics, John Wiley & Sons, Ltd., vol. 20(1), pages 16-26, January.
    5. Mike McKenna & Alan Maynard & Ken Wright, 1992. "Is rehabilitation cost effective?," Working Papers 101chedp, Centre for Health Economics, University of York.
    6. Paul Dolan & Claire Gudex, 1995. "Time preference, duration and health state valuations," Health Economics, John Wiley & Sons, Ltd., vol. 4(4), pages 289-299, July.
    7. Francis Asenso‐Boadi & Tim J. Peters & Joanna Coast, 2008. "Exploring differences in empirical time preference rates for health: an application of meta‐regression," Health Economics, John Wiley & Sons, Ltd., vol. 17(2), pages 235-248, February.
    8. Chu-chuan Cheng & Hsun Chu, 2018. "Optimal policies for sin goods and health care: Tax or subsidy?," International Tax and Public Finance, Springer;International Institute of Public Finance, vol. 25(2), pages 412-429, April.
    9. Townsend, Joy & Buxton, Martin, 1997. "Cost effectiveness scenario analysis for a proposed trial of hormone replacement therapy," Health Policy, Elsevier, vol. 39(3), pages 181-194, March.
    10. S. Höjgård & U. Enemark & C. H. Lyttkens & A. Lindgren & T. Troëng & H. Weibull, 2002. "Discounting and clinical decision making: Physicians, patients, the general public, and the management of asymptomatic abdominal aortic aneurysms," Health Economics, John Wiley & Sons, Ltd., vol. 11(4), pages 355-370, June.
    11. Virginia Wiseman & Craig Mitton & Mary M. Doyle‐Waters & Tom Drake & Lesong Conteh & Anthony T. Newall & Obinna Onwujekwe & Stephen Jan, 2016. "Using Economic Evidence to Set Healthcare Priorities in Low‐Income and Lower‐Middle‐Income Countries: A Systematic Review of Methodological Frameworks," Health Economics, John Wiley & Sons, Ltd., vol. 25(S1), pages 140-161, February.
    12. Alireza Mahboub-Ahari & Abolghasem Pourreza & Ali Akbari Sari & Trevor A Sheldon & Maryam Moeeni, 2019. "Private and social time preference for health outcomes: A general population survey in Iran," PLOS ONE, Public Library of Science, vol. 14(2), pages 1-13, February.
    13. Craig, Neil & Parkin, David & Gerard, Karen, 1995. "Clearing the fog on the Tyne: programme budgeting in Newcastle and North Tyneside Health Authority," Health Policy, Elsevier, vol. 33(2), pages 107-125, August.
    14. Salkeld, Glenn & Davey, Peter & Arnolda, Gaston, 1995. "A critical review of health-related economic evaluations in Australia: implications for health policy," Health Policy, Elsevier, vol. 31(2), pages 111-125, February.
    15. Bernard Berg & Werner Brouwer & Marc Koopmanschap, 2004. "Economic valuation of informal care," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 5(1), pages 36-45, February.
    16. Arthur E. Attema & Werner B. F. Brouwer & Karl Claxton, 2018. "Discounting in Economic Evaluations," PharmacoEconomics, Springer, vol. 36(7), pages 745-758, July.
    17. Magnus Johannesson & Joseph S. Pliskin & Milton C. Weinstein, 1994. "A Note on QALYs, Time Tradeoff, and Discounting," Medical Decision Making, , vol. 14(2), pages 188-193, April.
    18. van Exel, Job & Baker, Rachel & Mason, Helen & Donaldson, Cam & Brouwer, Werner, 2015. "Public views on principles for health care priority setting: Findings of a European cross-country study using Q methodology," Social Science & Medicine, Elsevier, vol. 126(C), pages 128-137.
    19. Shackley, Phil & Cairns, John, 1996. "Evaluating the benefits of antenatal screening: an alternative approach," Health Policy, Elsevier, vol. 36(2), pages 103-115, May.
    20. V. Srinivasan & David E. Bloom & Alex Khoury, 2022. "Forecasting the Incremental Value to Society Created by a Class of New Prescription Drugs: A Proposed Methodology and Its Application to Treating Chronic Hepatitis C in India," Applied Health Economics and Health Policy, Springer, vol. 20(3), pages 371-381, May.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:wly:hlthec:v:7:y:1998:i:1:p:21-29. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Wiley Content Delivery (email available below). General contact details of provider: http://www3.interscience.wiley.com/cgi-bin/jhome/5749 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.